Cargando…
Cell therapy demonstrates promise for acute respiratory distress syndrome - but which cell is best?
Acute respiratory distress syndrome (ARDS) constitutes a spectrum of increasingly severe acute respiratory failure and is the leading cause of death and disability in the critically ill. There are no therapies for ARDS, and management remains supportive. Cell therapy, particularly with allogeneic me...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706913/ https://www.ncbi.nlm.nih.gov/pubmed/23672885 http://dx.doi.org/10.1186/scrt179 |